Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Lanfang Medical Co., Ltd. Announcement on the Plan for Directors and Actual Controllers to Increase Their Shareholdings in the Company
Log in to the Sina Finance app, search for 【information disclosure】, and view more evaluation levels
Stock code: 002382 Stock abbreviation: Lain Medical Announcement No.: 2026-027
Bond code: 128108 Bond abbreviation: Lain Convertible Bond
Lain Medical Co., Ltd. Announcement on the Shareholding Increase Plan
by the Director and the Actual Controller
The director and actual controller, Mr. Li Zhenping, guarantees that the information provided to our company is true, accurate, and complete, and contains no false records, misleading statements, or material omissions.
Our company and all members of the board of directors guarantee that the contents of this announcement are consistent with the information provided by the information disclosure obligor.
Special Notice: Based on firm confidence in Lain Medical Co., Ltd.’s (hereinafter referred to as the “Company”) intrinsic value and in the Company’s future continued stable and healthy development, as well as in order to protect shareholders’ interests and enhance investors’ confidence, the Company’s director and actual controller, Mr. Li Zhenping, plans to increase the Company’s shares within 1 week from the date of this shareholding increase plan announcement (April 2, 2026–April 8, 2026), in accordance with relevant laws and regulations. The amount of this planned increase shall not be less than RMB 20 million (inclusive).
Recently, the Company received the “Notice Letter on the Shareholding Increase Plan of Lain Medical Co., Ltd.” issued by the Company’s director and actual controller, Mr. Li Zhenping. The relevant information is hereby announced as follows:
I. Current shareholding increase details
Basic information of the shareholding increase subject: the Company’s director and actual controller, Mr. Li Zhenping
Shareholding of the shareholding increase subject: Before the implementation of this shareholding increase plan, Mr. Li Zhenping directly held 5,552,618 shares of the Company, accounting for 0.55% of the Company’s total current share capital, and held 234,781,123 shares of the Company through Zibo Lain Investment Co., Ltd., accounting for 23.31% of the Company’s total current share capital.
Within the 12 months prior to the disclosure date of this announcement, Mr. Li Zhenping has not disclosed any shareholding increase plan; and within the 6 months prior to the disclosure date of this announcement, there has been no circumstance of reducing the Company’s shares.
II. Main contents of the shareholding increase plan
Purpose of the shareholding increase: Based on firm confidence in the Company’s intrinsic value and in the Company’s future continued stable and healthy development, and in order to protect shareholders’ interests and enhance investors’ confidence, Mr. Li Zhenping plans to increase his holdings of the Company’s shares.
Number or amount of shares to be increased: The amount of this planned increase shall not be less than RMB 20 million (inclusive).
Shareholding increase price: This shareholding increase plan does not set a price range. It will be implemented at an opportune time in accordance with fluctuations in the Company’s stock price and the overall trend in the capital market.
Implementation period of the shareholding increase plan: Taking into account factors such as market volatility and capital arrangements, Mr. Li Zhenping plans to increase the Company’s shares at an opportune time within 1 week from the date of disclosure of this shareholding increase plan announcement (April 2, 2026–April 8, 2026) (excluding the period(s) during which shareholding increase is not allowed under laws and regulations and the business rules of the Shenzhen Stock Exchange, etc.). During the implementation of the shareholding increase plan, if the Company’s stock is suspended from trading, the shareholding increase plan will be carried out after the resumption of trading and will be disclosed in a timely manner.
Method of the shareholding increase: It is proposed to increase the Company’s shares through centralized bidding trading on the Shenzhen Stock Exchange.
Source of the shareholding increase funds: It is proposed to use own funds or raised funds to carry out the increase.
This shareholding increase plan is not based on the specific identity of the shareholding increase subject. If the relevant identity is lost, the shareholding increase plan will continue to be implemented.
Apart from the lock-up period prescribed by relevant rules, there are no other lock-up arrangements in this shareholding increase plan.
Commitment of the shareholding increase subject: During the implementation period of this shareholding increase plan and within the statutory period, it will not reduce the Company shares held by it. It will strictly comply with relevant laws and regulations. Within the implementation period, it will complete the shareholding increase plan and will not engage in insider trading, trading of shares during sensitive periods, short-term trading, and other such conduct.
III. Uncertainty risk regarding the implementation of the shareholding increase plan
The implementation of this shareholding increase plan may involve risks such as delays in implementation or inability to implement due to factors including changes in capital market conditions and the progress of raising the shareholding increase funds not meeting expectations. If any relevant risk situations occur during the implementation of the shareholding increase plan, the Company will timely fulfill its information disclosure obligations. Investors are kindly requested to pay attention to investment risks.
IV. Other relevant explanations
This shareholding increase conduct complies with relevant laws and regulations such as the Securities Law, departmental rules, and the business rules of the Shenzhen Stock Exchange, among others.
The implementation of this shareholding increase plan will not affect the Company’s listing status, will not result in the Company’s equity distribution failing to meet listing conditions, and will not lead to changes in the Company’s controlling shareholder and actual controller.
This shareholding increase is based on the confidence of the Company’s director and actual controller, Mr. Li Zhenping, in the Company’s development prospects and his recognition of the Company’s long-term investment value. It does not constitute an investment recommendation to investors. Please investors note the investment risks.
V. Documents for reference
“Notice Letter on the Shareholding Increase Plan of Lain Medical Co., Ltd. Shares.”
This is hereby announced.
Lain Medical Co., Ltd.
Board of Directors
April 2, 2026
Stock code: 002382 Stock abbreviation: Lain Medical Announcement No.: 2026-027
Bond code: 128108 Bond abbreviation: Lain Convertible Bond
Lain Medical Co., Ltd.
Announcement on the Shareholding Increase Plan by the Director and Actual Controller
The director and actual controller, Mr. Li Zhenping, guarantees that the information provided to our company is true, accurate, and complete, and contains no false records, misleading statements, or material omissions.
Our company and all members of the board of directors guarantee that the contents of this announcement are consistent with the information provided by the information disclosure obligor.
Special Notice: Based on firm confidence in Lain Medical Co., Ltd.’s (hereinafter referred to as the “Company”) intrinsic value and in the Company’s future continued stable and healthy development, as well as in order to protect shareholders’ interests and enhance investors’ confidence, the Company’s director and actual controller, Mr. Li Zhenping, plans to increase the Company’s shares within 1 week from the date of this shareholding increase plan announcement (April 2, 2026–April 8, 2026), in accordance with relevant laws and regulations. The amount of this planned increase shall not be less than RMB 20 million (inclusive).
Recently, the Company received the “Notice Letter on the Shareholding Increase Plan of Lain Medical Co., Ltd.” issued by the Company’s director and actual controller, Mr. Li Zhenping. The relevant information is hereby announced as follows:
I. Current shareholding increase details
Basic information of the shareholding increase subject: the Company’s director and actual controller, Mr. Li Zhenping
Shareholding of the shareholding increase subject: Before the implementation of this shareholding increase plan, Mr. Li Zhenping directly held 5,552,618 shares of the Company, accounting for 0.55% of the Company’s total current share capital, and held 234,781,123 shares of the Company through Zibo Lain Investment Co., Ltd., accounting for 23.31% of the Company’s total current share capital.
Within the 12 months prior to the disclosure date of this announcement, Mr. Li Zhenping has not disclosed any shareholding increase plan; and within the 6 months prior to the disclosure date of this announcement, there has been no circumstance of reducing the Company’s shares.
II. Main contents of the shareholding increase plan
Purpose of the shareholding increase: Based on firm confidence in the Company’s intrinsic value and in the Company’s future continued stable and healthy development, and in order to protect shareholders’ interests and enhance investors’ confidence, Mr. Li Zhenping plans to increase his holdings of the Company’s shares.
Number or amount of shares to be increased: The amount of this planned increase shall not be less than RMB 20 million (inclusive).
Shareholding increase price: This shareholding increase plan does not set a price range. It will be implemented at an opportune time in accordance with fluctuations in the Company’s stock price and the overall trend in the capital market.
Implementation period of the shareholding increase plan: Taking into account factors such as market volatility and capital arrangements, Mr. Li Zhenping plans to increase the Company’s shares at an opportune time within 1 week from the date of disclosure of this shareholding increase plan announcement (April 2, 2026–April 8, 2026) (excluding the period(s) during which shareholding increase is not allowed under laws and regulations and the business rules of the Shenzhen Stock Exchange, etc.). During the implementation of the shareholding increase plan, if the Company’s stock is suspended from trading, the shareholding increase plan will be carried out after the resumption of trading and will be disclosed in a timely manner.
Method of the shareholding increase: It is proposed to increase the Company’s shares through centralized bidding trading on the Shenzhen Stock Exchange.
Source of the shareholding increase funds: It is proposed to use own funds or raised funds to carry out the increase.
This shareholding increase plan is not based on the specific identity of the shareholding increase subject. If the relevant identity is lost, the shareholding increase plan will continue to be implemented.
Apart from the lock-up period prescribed by relevant rules, there are no other lock-up arrangements in this shareholding increase plan.
Commitment of the shareholding increase subject: During the implementation period of this shareholding increase plan and within the statutory period, it will not reduce the Company shares held by it. It will strictly comply with relevant laws and regulations. Within the implementation period, it will complete the shareholding increase plan and will not engage in insider trading, trading of shares during sensitive periods, short-term trading, and other such conduct.
III. Uncertainty risk regarding the implementation of the shareholding increase plan
The implementation of this shareholding increase plan may involve risks such as delays in implementation or inability to implement due to factors including changes in capital market conditions and the progress of raising the shareholding increase funds not meeting expectations. If any relevant risk situations occur during the implementation of the shareholding increase plan, the Company will timely fulfill its information disclosure obligations. Investors are kindly requested to pay attention to investment risks.
IV. Other relevant explanations
This shareholding increase conduct complies with relevant laws and regulations such as the Securities Law, departmental rules, and the business rules of the Shenzhen Stock Exchange, among others.
The implementation of this shareholding increase plan will not affect the Company’s listing status, will not result in the Company’s equity distribution failing to meet listing conditions, and will not lead to changes in the Company’s controlling shareholder and actual controller.
This shareholding increase is based on the confidence of the Company’s director and actual controller, Mr. Li Zhenping, in the Company’s development prospects and his recognition of the Company’s long-term investment value. It does not constitute an investment recommendation to investors. Please investors note the investment risks.
V. Documents for reference
“Notice Letter on the Shareholding Increase Plan of Lain Medical Co., Ltd. Shares.”
This is hereby announced.
Lain Medical Co., Ltd.
Board of Directors
April 2, 2026
Massive information and precise interpretation—available in the Sina Finance app